Status: Recruiting
Postoperative Basal Bolus or Sliding Scale Insulin Regimen in DM2 and Its Effect on Surgical Site Infections.
A multicentre, matched-pair, cluster randomised controlled superiority trial to investigate the effect of a proactive basal bolus insulin regimen compared to the reactive sliding scale insulin regimen, targeting a glucose level of 3.9-10.0 mmol/L, to reduce the number of surgical site infections within the first 30 days postoperatively in adult patients with diabetes mellitus type 2.
Participants needed: 1,008
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Abraham Hulst, MD, PhDUpdated: Jan 30, 2025Locations: 1
Eligibility criteria
Patients aged 18 or older [+5]
Diagnosed with type 1 diabetes mellitus [+5]